Oruka Therapeutics, Inc.
Filed with the SEC on · accession 9999999995-26-002787
ORKA filed a EFFECT (effect) with the SEC on Aug 27, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.9% by the first close after the filing.
Oruka Therapeutics, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
Close before
$99.44
Aug 26, 2026
First close after
-2.92%
$96.54
5 trading days
-7.85%
$91.63
Since filing
+3.44%
$102.86
✦ Ask GOAX AI about this filing — what it means for ORKA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ORKA?
Click hereORKA filed a EFFECT (SEC filing). Oruka Therapeutics, Inc. filed an EFFECT notice with the SEC, indicating that a previously filed registration statement has become effective.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A EFFECT (effect): A report the company filed with the SEC (the US market regulator).
ORKA closed at $99.44 before the filing and $96.54 on Aug 27, 2026 (-2.92%). Five trading days later: $91.63 (-7.85%).
Get alerts when ORKA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days